614 related articles for article (PubMed ID: 18977585)
1. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
Alrefai AH; Aburahma SK; Khader YS
Clin Neurol Neurosurg; 2009 Jan; 111(1):79-82. PubMed ID: 18977585
[TBL] [Abstract][Full Text] [Related]
2. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Banerjee KJ; Glasson C; O'Flaherty SJ
Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
Wu KP; Ke JY; Chen CY; Chen CL; Chou MY; Pei YC
J Child Neurol; 2011 Jul; 26(7):838-43. PubMed ID: 21551374
[TBL] [Abstract][Full Text] [Related]
4. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
Jongerius PH; van den Hoogen FJ; van Limbeek J; Gabreëls FJ; van Hulst K; Rotteveel JJ
Pediatrics; 2004 Sep; 114(3):620-7. PubMed ID: 15342830
[TBL] [Abstract][Full Text] [Related]
5. The use of botulinum toxic injection to treat excessive drooling in children with neurological conditions.
Khan A; Pawar G
W V Med J; 2005; 101(6):258-60. PubMed ID: 16625812
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B.
Wilken B; Aslami B; Backes H
Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707
[TBL] [Abstract][Full Text] [Related]
8. Botulinum toxin type B for sialorrhoea in children with cerebral palsy: a randomized trial comparing three doses.
Basciani M; Di Rienzo F; Fontana A; Copetti M; Pellegrini F; Intiso D
Dev Med Child Neurol; 2011 Jun; 53(6):559-64. PubMed ID: 21413974
[TBL] [Abstract][Full Text] [Related]
9. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy.
Savarese R; Diamond M; Elovic E; Millis SR
Am J Phys Med Rehabil; 2004 Apr; 83(4):304-11; quiz 312-4, 336. PubMed ID: 15024333
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
Verma A; Steele J
Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
[TBL] [Abstract][Full Text] [Related]
11. Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care.
Van der Burg JJ; Jongerius PH; Van Hulst K; Van Limbeek J; Rotteveel JJ
Dev Med Child Neurol; 2006 Feb; 48(2):103-7. PubMed ID: 16417664
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.
Chinnapongse R; Gullo K; Nemeth P; Zhang Y; Griggs L
Mov Disord; 2012 Feb; 27(2):219-26. PubMed ID: 21887710
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of botulinum toxin injections into the salivary glands to reduce drooling in children with neurological disorders.
Reid SM; Johnstone BR; Westbury C; Rawicki B; Reddihough DS
Dev Med Child Neurol; 2008 Feb; 50(2):123-8. PubMed ID: 18201301
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and duration of botulinum toxin treatment for drooling in 131 children.
Scheffer AR; Erasmus C; van Hulst K; van Limbeek J; Jongerius PH; van den Hoogen FJ
Arch Otolaryngol Head Neck Surg; 2010 Sep; 136(9):873-7. PubMed ID: 20855679
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin A in the treatment of sialorrhea.
Benson J; Daugherty KK
Ann Pharmacother; 2007 Jan; 41(1):79-85. PubMed ID: 17190848
[TBL] [Abstract][Full Text] [Related]
17. Thickened saliva after effective management of drooling with botulinum toxin A.
Erasmus CE; Van Hulst K; Van Den Hoogen FJ; Van Limbeek J; Roeleveld N; Veerman EC; Rotteveel JJ; Jongerius PH
Dev Med Child Neurol; 2010 Jun; 52(6):e114-8. PubMed ID: 20163435
[TBL] [Abstract][Full Text] [Related]
18. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
Porte M; Chaléat-Valayer E; Patte K; D'Anjou MC; Boulay C; Laffont I
Eur J Paediatr Neurol; 2014 Nov; 18(6):649-57. PubMed ID: 24931915
[TBL] [Abstract][Full Text] [Related]
19. Use of botulinum neurotoxin A in uncontrolled salivation in children with cerebral palsy: a pilot study.
Tiigimäe-Saar J; Leibur E; Kolk A; Talvik I; Tamme T
Int J Oral Maxillofac Surg; 2012 Dec; 41(12):1540-5. PubMed ID: 23068112
[TBL] [Abstract][Full Text] [Related]
20. What could predict effectiveness of Botulinum Toxin to treat drooling: a search for evidence of discriminatory factors on the level of body functions or structures.
Erasmus CE; van Hulst K; Scheffer AR; van Limbeek J; van den Hoogen FJ; Rotteveel JJ; Jongerius PH
Eur J Paediatr Neurol; 2012 Mar; 16(2):126-31. PubMed ID: 21783393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]